An anesthetic
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Product Categories

Product Type

Oxybuprocaine (hydrochloride)

Item No. 39978

Technical Information
Formal Name
4-amino-3-butoxy-benzoic acid, 2-(diethylamino)ethyl ester, monohydrochloride
CAS Number
5987-82-6
Synonyms
  • Benoxinate
  • Dorsacaine
Molecular Formula
C17H28N2O3 • HCl
Formula Weight
Purity
≥95%
A solid
DMSO: Sparingly Soluble: 1-10 mg/mlEthanol: Sparingly Soluble: 1-10 mg/mlPBS (pH 7.2): Soluble: ≥10 mg/ml
SMILES
O=C(C(C=C1)=CC(OCCCC)=C1N)OCCN(CC)CC.Cl
InChi Code
InChI=1S/C17H28N2O3.ClH/c1-4-7-11-21-16-13-14(8-9-15(16)18)17(20)22-12-10-19(5-2)6-3;/h8-9,13H,4-7,10-12,18H2,1-3H3;1H
InChi Key
PRGUDWLMFLCODA-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Wet ice in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Product Description

    Oxybuprocaine is an anesthetic.1 Intrathecal administration of oxybuprocaine reduces motor function, decreases righting behaviors in the placement test, and increases latency to paw withdrawal in the hot plate test in rats (ED50s = 0.43, 0.5, and 0.31 µmol/kg, respectively). Topical application of oxybuprocaine (0.4% w/v) reduces corneal sensitivity in the corneal touch test in dogs.2 Formulations containing oxybuprocaine have been used to induce anesthesia prior to ocular surgery.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Hung, C.-H., Wang, J.-J., Chen, Y.-C., et alIntrathecal oxybuprocaine and proxymetacaine produced potent and long-lasting spinal anesthesia in rats. Neurosci. Lett. 454(3), (2009).

    2. Douet, J.-Y., Michel, J., and Regnier, A. Degree and duration of corneal anesthesia after topical application of 0.4% oxybuprocaine hydrochloride ophthalmic solution in ophthalmically normal dogs. Am. J. Vet. Res. 74(10), 1321-1326 (2013).